We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Molecular Diagnostic Solution Aids in Early Detection of Hepatitis

By LabMedica International staff writers
Posted on 12 Jun 2023

Over 350 million people worldwide are afflicted with viral hepatitis, with 9 out of 10 hepatitis sufferers unaware of their condition. More...

To tackle this issue, Tianlong Science and Technology (Shaanxi, China), an innovative high-tech company specializing in molecular diagnostic products, has joined forces with public hospitals in northern Thailand. The partnership aims to provide detection for hepatitis C (HCV) and hepatitis B (HBV), facilitating early diagnosis and treatment. Tianlong's detection solution for HCV and HBV can aid in curbing the transmission of the diseases through early diagnosis and appropriate treatment.

Since October 2022, public hospitals in Thailand have successfully implemented Tianlong's HCV and HBV detection solution. The reagents developed by Tianlong for HCV and HBV detection, compatible with its PANA9600S nucleic acid extractor and Gentier 96 PCR system, enable rapid testing with high sensitivity, thereby gaining traction among high-end users. Tianlong has established a 7-year agreement with local Thai hospitals, which plan to progressively adopt its HCV and HBV detection solution. This move has paved the way for Tianlong to penetrate the Thai market and allowed it to strengthen its engagement with local high-end users.

Tianlong is determined to widen its footprint in Thailand, closely collaborating with local partners to deliver top-notch solutions and services for its customers. The company also plans to introduce its STIs kits in Thailand shortly, aiming to curb the spread of sexually transmitted infections (STIs). Tianlong anticipates that its molecular diagnostic solutions for hepatitis and other diseases will gain increasing acceptance in the local market, contributing to the health and well-being of the people in Thailand.

"Tianlong can give timely responses both online and offline when we need technical support. We have great confidence in Tianlong's products, and we would welcome more cooperation in the future," said a local hospital representative in Thailand.

Related Links:
Tianlong Science and Technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
HPV Test
Allplex HPV28 Detection
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.